{'52WeekChange': -0.51166666,
 'SandP52WeekChange': 0.0644362,
 'address1': '9 Fishers Lane',
 'address2': 'Suite E',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 3.5,
 'askSize': 2200,
 'averageDailyVolume10Day': 3425,
 'averageVolume': 14009,
 'averageVolume10days': 3425,
 'beta': 4.97509,
 'beta3Year': None,
 'bid': 2.88,
 'bidSize': 2200,
 'bookValue': -1.162,
 'category': None,
 'circulatingSupply': None,
 'city': 'Sparta',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.93,
 'dayLow': 2.88,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -2.584,
 'enterpriseToRevenue': 146.017,
 'enterpriseValue': 36566708,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '973-843-6300',
 'fiftyDayAverage': 3.1763713,
 'fiftyTwoWeekHigh': 6.534,
 'fiftyTwoWeekLow': 1.8,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 6829197,
 'forwardEps': -0.92,
 'forwardPE': -3.152174,
 'fromCurrency': None,
 'fullTimeEmployees': 10,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.02301,
 'heldPercentInstitutions': 0.22443001,
 'industry': 'Drug Manufacturers—Specialty & Generic',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1492646400,
 'lastSplitFactor': '1:8',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/plxpharma.com',
 'longBusinessSummary': 'PLx Pharma Inc., a late-stage specialty '
                        'pharmaceutical company, focuses on developing its '
                        'PLxGuard delivery system to provide various products '
                        "in the United States. The company's lead product "
                        'candidates are Vazalore 325 mg and Vazalore 81 mg, '
                        'which are formulations of aspirin that use the '
                        'PLxGuard delivery system to reduce acute '
                        'gastrointestinal (GI) side effects while providing '
                        'antiplatelet effectiveness for cardiovascular disease '
                        'prevention. Its product pipeline also includes other '
                        'oral non-steroidal anti-inflammatory drugs using the '
                        'PLxGuard delivery system, such as PL1200 Ibuprofen '
                        '200 mg, a GI-safer ibuprofen product for pain and '
                        'inflammation, as well as PL1100 Ibuprofen 400 mg. The '
                        'company was founded in 2002 and is based in Sparta, '
                        'New Jersey.',
 'longName': 'PLx Pharma Inc.',
 'market': 'us_market',
 'marketCap': 26553154,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_8265626',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -9877364,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.88,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.07,
 'phone': '973-409-6541',
 'previousClose': 2.9,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 106.03152,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.93,
 'regularMarketDayLow': 2.88,
 'regularMarketOpen': 2.88,
 'regularMarketPreviousClose': 2.9,
 'regularMarketPrice': 2.88,
 'regularMarketVolume': 3787,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 9156260,
 'sharesPercentSharesOut': 0.015,
 'sharesShort': 137740,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 138387,
 'shortName': 'PLx Pharma Inc.',
 'shortPercentOfFloat': 0.018099999,
 'shortRatio': 11.34,
 'startDate': None,
 'state': 'NJ',
 'strikePrice': None,
 'symbol': 'PLXP',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.095,
 'twoHundredDayAverage': 3.6724172,
 'volume': 3787,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://plxpharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '07871'}